● Recruiting

ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa

Condition: Prostate Cancer · Sponsor: Hospital of Macerata

PhaseN/A

Planned participants534

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

Study wants to explore real-world data in three distinct settings * Patients with metachronous or de novo mCSPC treated with ADT+ARSI or ADT+ARSI+docetaxel \_ARON-3S * Patients receiving Lutetium-177 PSMA for mCRPC \_ ARON-3Lu * Patients treated with PARP inhibitors (alone or combined with ARSI) for CRPC \_ ARON-3GEN

This description comes directly from the study's public registry record.

Talk to the study team

Matteo Santoni · +39 07332573752 · sorgentoni.giulia@gmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Ospedale di Macerata

Province of Macerata, Macerata, Italy

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06200558